Joseph Pitts actually said...

"FDA has admitted that the proposed changes will open generic manufacturers up to greater liability under state tort lawsuits."

"The proposed rule undermines the 'sameness' requirement in Hatch-Waxman and will result in situations where multiple FDA-approved, therapeutically equivalent products will have different safety-relate..."

"The only outcome I see if the rule is enacted is mass confusion."

"One of the great successes in healthcare in the past 30 years has been the introduction and widespread use of generic drugs, saving patients and taxpayers trillions of dollars."